Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
What GLP-1 Users Are Buying Are Buying Heres how GLP-1 influenced behavior is showing up on shelves: Higher demand for protein and fiber: Lean proteins, meat snacks, Greek yogurt, and nutrient-dense options are performing well, while sugary, high-calorie snacks are declining
A Bridge to Fertility Treatment Many women using GLP-1 drugs are thinking ahead to pregnancy, and trying to understand how their weight loss, metabolic health and medications might impact their plans
Endocrinology, 151(4), 14731486
Retatrutide (LY3437943) is a peptide developed by Eli Lilly that acts on three different metabolic receptors simultaneously: GLP-1 receptor GIP receptor Glucagon receptor This makes Retatrutide the first triple-agonist peptide to reach advanced Phase 3 clinical development
Lancet 2019;394(10208):1519e29
Your healthcare provider will tell you when and how often to take your medication (usually injections)
US$ 22.08
US$ 28.83
US$ 25.84
US$ 25.91
US$ 22.03
US$ 25.85
US$ 25.18
US$ 26.05
US$ 22.04
US$ 26.38
